On Monday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) opened higher 4.80% from the last session, before settling in for the closing price of $3.96. Price fluctuations for IRWD have ranged from $3.79 to $15.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 5.56% over the last five years. Company’s average yearly earnings per share was noted 103.08% at the time writing. With a float of $155.59 million, this company’s outstanding shares have now reached $156.35 million.
The firm has a total of 267 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.49%, operating margin of 30.69%, and the pretax margin is 21.5%.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Ironwood Pharmaceuticals Inc is 2.60%, while institutional ownership is 108.47%. The most recent insider transaction that took place on Aug 12 ’24, was worth 42,316. In this transaction Chief Legal Officer of this company sold 9,910 shares at a rate of $4.27, taking the stock ownership to the 284,661 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Principal Accounting Officer sold 3,107 for $4.27, making the entire transaction worth $13,267. This insider now owns 158,370 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.09 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.16) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 103.08% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Check out the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). In the past quarter, the stock posted a quick ratio of 3.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.65. Likewise, its price to free cash flow for the trailing twelve months is 4.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.34 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Analysing the last 5-days average volume posted by the [Ironwood Pharmaceuticals Inc, IRWD], we can find that recorded value of 0.92 million was lower than the volume posted last year of 3.0 million. As of the previous 9 days, the stock’s Stochastic %D was 20.00%. Additionally, its Average True Range was 0.24.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 10.86%, which indicates a significant decrease from 37.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.32% in the past 14 days, which was lower than the 85.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.40, while its 200-day Moving Average is $7.57. Now, the first resistance to watch is $4.32. This is followed by the second major resistance level at $4.49. The third major resistance level sits at $4.61. If the price goes on to break the first support level at $4.02, it is likely to go to the next support level at $3.90. Should the price break the second support level, the third support level stands at $3.73.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are currently 156,529K shares outstanding in the company with a market cap of 662.92 million. Presently, the company’s annual sales total 442,740 K according to its annual income of -1,002 M. Last quarter, the company’s sales amounted to 94,400 K and its income totaled -860 K.
